Oral Cavity Verrucous Carcinoma

subtype

Identifier: CI-CAN-00006184
Entity page: /cancer/oral-cavity-verrucous-carcinoma ↗
Edges: 83

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Oral Cavity Verrucous Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 29show all (up to 200)
→ investigated in trials for	Cetuximabmonoclonal antibody 10 trials (0 active) · roll-up of the cancer and its descendants	—	—	Oral Cavity Verrucous Carcinoma	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinib Hydrochloride

Oral Cavity Verrucous Carcinoma studied in …STUDIED_INderived10 of 54show all (up to 200)
→ studied in	NCT02734537Phase 2 · recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery · condition mapped CURATED_BROADER · 54 trials mapped (3 active)	—	—	Oral Cavity Verrucous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 54 trials mapped (3 active)	—	—	Oral Cavity Verrucous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00939627Phase 2 · completed Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab · condition mapped CURATED_BROADER · 54 trials mapped (3 active)	—	—	Oral Cavity Verrucous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01473784NA · recruiting Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck · condition mapped CURATED_BROADER · 54 trials mapped (3 active)	—	—	Oral Cavity Verrucous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02245100completed Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 54 trials mapped (3 active)	—	—	Oral Cavity Verrucous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01847326Phase 1 · completed Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 54 trials mapped (3 active)	—	—	Oral Cavity Verrucous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01332279Phase 1 · withdrawn Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy · condition mapped CURATED_BROADER · 54 trials mapped (3 active)	—	—	Oral Cavity Verrucous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02295540NA · withdrawn Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity · condition mapped CURATED_BROADER · 54 trials mapped (3 active)	—	—	Oral Cavity Verrucous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00470496Phase 1 · completed Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 54 trials mapped (3 active)	—	—	Oral Cavity Verrucous Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01816984Phase 1/Phase 2 · completed PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 54 trials mapped (3 active)	—	—	Oral Cavity Verrucous Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains